Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Острые респираторные вирусные инфекции у детей: принципы терапии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Мельникова М.А. Острые респираторные инфекции с синдромом бронхообструкции у детей первых 3 лет жизни и показатели его рецидивирования. Автореф. дис. … канд. мед. наук. М., 2010.
2. Baskin M. The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life. Pediatr Ann 1993; 22: 462–6.
3. Beasley R et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372 (9643): 1039–48.
4. Beers M, Berkow R (Eds). The Merck Manual of diagnosis and therapy. 17th ed. New York: published by Merck Research Laboratories, 1999.
5. Chiu C, Lin T, Bullard M. Identification of febrile neonates unlikely to have bacterial infections. Pediatr Infect Dis J 1997; 16: 59–63.
6. Czaykowski D, Fratarcangelo P, Rosefsky J. Evaluation of the antipyretic efficacy of single dose ibuprofen suspension compared to acetaminophen elixir in febrile children. Pediatr Res 1994; 35: 4 (Pt 2, Abstr. 829).
7. Feverish illness in children. Assessment and initial management in children younger than 5 years. NICE clinical guideline 47 developed by the national collaborating centre for women and children health, 2007.
8. Hay W, Hayward A, Lewin M (Eds). Current pediatric diagnosis and treatment. 16th ed. New York : McGraw Hill, 2003; p. 237–9.
9. Illing S, Classen M. Klinik Leitfaden. Pädiatrie 5 (neu bearbeitete Auflage). Muenchen: Urban & Fiescher, 2000; s. 161.
10. Jaskiewicz J, McCarthy C, Richardson A et al. Febrile infants at low risk for serious bacterial infection – an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 1994; 94: 390–6.
11. Salmon D A, Proschan M et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 2013; 381: 1461–8.
12. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109 (2): E20.
13. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995; 273 (12): 929–33.
14. Luszczak M. Evaluation and management of infants and young children with fever. Am Fam Physician 2001; 64: 1219–26.
15. Manley J, Taddio A. Acetaminophen and ibuprofen for prevention of adverse reaction associated with childhood immunization. Ann Pharmacother 2007; 41: 1227–32.
16. McBride JT. The association of acetaminophen and asthma prevalence and severity. Pediatrics 2011; 128 (6): 1181–5.
17. Nabulsi M, Tamimi H, Mahfound Z et al. Alternating ibuprofen and acetaminophen in the treatment of fedrile children: a pilot study [JSRCTN30487061]. BMC Medicine 2006; 4. URL: http://www.biomedcentral.com/1741-7015/4/4
18. Noyola DE, Fernandez M, Kaplan SL. Reevaluation of antipyretics in children with enteric fever. Pediatr Infect Dis J 1998; 17 (8): 691–5.
19. Siegenthaler W (Hrsg.) Differentialdiagnose innerer Krankheiten. 17 (neu bearbeitete Auflage). Stuttgart: Georg Thieme Verlag, 1993.
20. Sulvivan J, Farrar H. Clinical report – fever and antipyretic use in children. Pediatrics 2011; 127: 581–7.
21. Temperature measurements in children. URL: http://www.cps.ca/
english/statements/CP/cp00-01.htm
22. The management of fever in young children with acute respiratory infections in developing countries. WHO/ARI/93.90. Geneva, 1993.
23. Vinh H, Parry C, Hangh V et al. Double blend comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever. Pediatr Infect Dis J 2004; 23: 226–30.
24. Walsh A, Edwards H, Fraser J. Over-the-counter medications use for childhood fever: a cross-sectional study of Australian parents. J Pediatr Child Health 2007; 43: 601–6.
2. Baskin M. The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life. Pediatr Ann 1993; 22: 462–6.
3. Beasley R et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372 (9643): 1039–48.
4. Beers M, Berkow R (Eds). The Merck Manual of diagnosis and therapy. 17th ed. New York: published by Merck Research Laboratories, 1999.
5. Chiu C, Lin T, Bullard M. Identification of febrile neonates unlikely to have bacterial infections. Pediatr Infect Dis J 1997; 16: 59–63.
6. Czaykowski D, Fratarcangelo P, Rosefsky J. Evaluation of the antipyretic efficacy of single dose ibuprofen suspension compared to acetaminophen elixir in febrile children. Pediatr Res 1994; 35: 4 (Pt 2, Abstr. 829).
7. Feverish illness in children. Assessment and initial management in children younger than 5 years. NICE clinical guideline 47 developed by the national collaborating centre for women and children health, 2007.
8. Hay W, Hayward A, Lewin M (Eds). Current pediatric diagnosis and treatment. 16th ed. New York : McGraw Hill, 2003; p. 237–9.
9. Illing S, Classen M. Klinik Leitfaden. Pädiatrie 5 (neu bearbeitete Auflage). Muenchen: Urban & Fiescher, 2000; s. 161.
10. Jaskiewicz J, McCarthy C, Richardson A et al. Febrile infants at low risk for serious bacterial infection – an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 1994; 94: 390–6.
11. Salmon D A, Proschan M et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 2013; 381: 1461–8.
12. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109 (2): E20.
13. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995; 273 (12): 929–33.
14. Luszczak M. Evaluation and management of infants and young children with fever. Am Fam Physician 2001; 64: 1219–26.
15. Manley J, Taddio A. Acetaminophen and ibuprofen for prevention of adverse reaction associated with childhood immunization. Ann Pharmacother 2007; 41: 1227–32.
16. McBride JT. The association of acetaminophen and asthma prevalence and severity. Pediatrics 2011; 128 (6): 1181–5.
17. Nabulsi M, Tamimi H, Mahfound Z et al. Alternating ibuprofen and acetaminophen in the treatment of fedrile children: a pilot study [JSRCTN30487061]. BMC Medicine 2006; 4. URL: http://www.biomedcentral.com/1741-7015/4/4
18. Noyola DE, Fernandez M, Kaplan SL. Reevaluation of antipyretics in children with enteric fever. Pediatr Infect Dis J 1998; 17 (8): 691–5.
19. Siegenthaler W (Hrsg.) Differentialdiagnose innerer Krankheiten. 17 (neu bearbeitete Auflage). Stuttgart: Georg Thieme Verlag, 1993.
20. Sulvivan J, Farrar H. Clinical report – fever and antipyretic use in children. Pediatrics 2011; 127: 581–7.
21. Temperature measurements in children. URL: http://www.cps.ca/
english/statements/CP/cp00-01.htm
22. The management of fever in young children with acute respiratory infections in developing countries. WHO/ARI/93.90. Geneva, 1993.
23. Vinh H, Parry C, Hangh V et al. Double blend comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever. Pediatr Infect Dis J 2004; 23: 226–30.
24. Walsh A, Edwards H, Fraser J. Over-the-counter medications use for childhood fever: a cross-sectional study of Australian parents. J Pediatr Child Health 2007; 43: 601–6.
Авторы
В.М.Делягин
ФГБУ Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Д.Рогачева Минздрава РФ, Москва
Кафедра поликлинической педиатрии ГБОУ ВПО Российский научно-исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ, Москва
ФГБУ Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Д.Рогачева Минздрава РФ, Москва
Кафедра поликлинической педиатрии ГБОУ ВПО Российский научно-исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.